Correlation Between Arhaus and Neumora Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Arhaus and Neumora Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arhaus and Neumora Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arhaus Inc and Neumora Therapeutics, Common, you can compare the effects of market volatilities on Arhaus and Neumora Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arhaus with a short position of Neumora Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arhaus and Neumora Therapeutics,.

Diversification Opportunities for Arhaus and Neumora Therapeutics,

-0.57

Correlation Coefficient

Arhaus  Neumora Therapeutics,

Excellent diversification

The 3 months correlation between Arhaus and Neumora is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Arhaus Inc and Neumora Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neumora Therapeutics, and Arhaus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arhaus Inc are associated (or correlated) with Neumora Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neumora Therapeutics, has no effect on the direction of Arhaus i.e., Arhaus and Neumora Therapeutics, go up and down completely randomly.

Pair Corralation between Arhaus and Neumora Therapeutics,

Given the investment horizon of 90 days Arhaus Inc is expected to generate 0.53 times more return on investment than Neumora Therapeutics,. However, Arhaus Inc is 1.88 times less risky than Neumora Therapeutics,. It trades about 0.01 of its potential returns per unit of risk. Neumora Therapeutics, Common is currently generating about -0.04 per unit of risk. If you would invest  1,405  in Arhaus Inc on October 25, 2024 and sell it today you would lose (219.00) from holding Arhaus Inc or give up 15.59% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	68.97%
Values	Daily Returns

Arhaus Inc  vs.  Neumora Therapeutics, Common

Arhaus Inc

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Arhaus Inc are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady technical indicators, Arhaus unveiled solid returns over the last few months and may actually be approaching a breakup point.

Neumora Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neumora Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Arhaus and Neumora Therapeutics,

The main advantage of trading using opposite Arhaus and Neumora Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arhaus position performs unexpectedly, Neumora Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neumora Therapeutics, will offset losses from the drop in Neumora Therapeutics,'s long position.

The idea behind Arhaus Inc and Neumora Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..